Intel stock beats Q2 expectations, Benchmark reiterates Hold rating

Intel's recent financial reporting presents a mixed picture: one section indicates strong second-quarter revenue and adjusted EPS beats with robust Q3 revenue guidance, while another details a significant earnings per share miss ($-0.10 vs. $0.01 anticipated) for its 'second-quarter 2025' results, coupled with substantial impairment charges and margin pressure. This dichotomy has led to a maintained Hold rating by Benchmark and a lowered price target by HSBC, reflecting both operational strengths and ongoing financial headwinds for the semiconductor giant.

Analysis

Intel's recent financial disclosures present a dichotomous view, characterized by top-line resilience but significant bottom-line and margin deterioration. According to a Benchmark report, the company's second-quarter revenue surpassed forecasts by approximately $930 million, driven by a healthy PC market and pre-tariff demand. This strength extends to the forward outlook, with third-quarter revenue guidance pointing to a midpoint $440 million above consensus. However, this positive revenue picture is sharply contrasted by severe profitability pressures. A separate report from HSBC highlights a significant earnings per share miss for its Q2 2025 results, coming in at -$0.10 versus a $0.01 consensus, alongside a gross margin of 29.7% which fell short of the 36.5% guidance. Profitability was further eroded by $1 billion in one-time costs, including $800 million in impairment charges. This has led analysts to a cautious consensus, with both Benchmark and HSBC maintaining 'Hold' ratings, and HSBC lowering its price target to $21.25, reflecting that the ongoing earnings and margin challenges currently overshadow the revenue outperformance.

Key Decisions for Investors

• Investors should prioritize analyzing Intel's margin trajectory over its revenue growth, as the significant EPS miss and gross margin compression to 29.7% indicate that profitability remains a primary concern.
• It is critical to evaluate the nature of the $1 billion in impairment and restructuring charges to determine if they are truly one-time events or signal deeper, recurring operational headwinds.
• Given the consistent 'Hold' ratings from analysts despite mixed signals, a neutral stance on the stock may be warranted until the company demonstrates a clear and sustainable path back to margin expansion and earnings predictability.